Ultrazonix AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ultrazonix AB - overview
Established
1998
Location
Malmo, -, Sweden
Primary Industry
Healthcare
About
Founded in 1998, Ultrazonix AB is a Sweden-based company that operates as a developer of medical equipment and therapeutic products.
Primary Industry
Healthcare
Sub Industries
Medical Equipment Distributors
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Ultrazonix AB - financials
| Fiscal Year Ended | Dec 31, 2003 | Dec 31, 2004 | Dec 31, 2005 | Dec 31, 2006 | Dec 31, 2007 | Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | (18,409,390) | (17,787,982) | (20,565,724) | (18,845,728) | (11,092,893) | (7,627,700) | (1,074,399) | - | - | - |
| Operating Income (USD) | (18,726,290) | (18,216,735) | (21,108,888) | (19,448,625) | (11,663,225) | (7,843,184) | (1,168,179) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (19,253,208) | (19,520,360) | (21,088,172) | (20,660,521) | (12,523,213) | (7,975,046) | (1,244,508) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - |
Ultrazonix AB - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.